A19.0

Clinical Causes: Mycobacterium tuberculosis infection Spread from a primary pulmonary tuberculosis site Hematogenous dissemination of bacteria through the bloodstream Potential reactivation of dormant tuberculosis bacteria Weakened immune system increasing susceptibility

Key Symptoms: Fever and chills Night sweats Unintentional weight loss Fatigue and general weakness Localized symptoms depending on the affected site Loss of appetite Persistent cough if the lungs are involved

Diagnosis Path: Diagnosis typically involves a combination of clinical evaluation and laboratory tests. Chest X-rays or imaging studies help identify localized or disseminated lesions. Microbiological examination of tissue or bodily fluids, such as sputum, may reveal Mycobacterium tuberculosis. Blood tests like the tuberculosis skin test or interferon-gamma release assays (IGRAs) can support the diagnosis. In some cases, a biopsy of the affected tissue may be necessary to confirm the presence of tuberculosis bacteria.

Treatment Protocols: Treatment generally involves a prolonged course of multiple antibiotics specifically targeting tuberculosis bacteria. Standard therapy includes drugs such as isoniazid, rifampin, ethambutol, and pyrazinamide, usually administered over several months. Hospitalization may be needed initially, especially in severe cases, to monitor response to therapy and manage complications. Regular follow-up and testing are essential to ensure the infection is effectively treated and to prevent relapse.